Profile data is unavailable for this security.
About the company
Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
- Revenue in NOK (TTM)218.51m
- Net income in NOK-106.68m
- Incorporated2009
- Employees62.00
- LocationHofseth Biocare ASAKipervikgata 13ALESUND 6003NorwayNOR
- Phone+47 73102200
- Fax+47 66765562
- Websitehttps://hofsethbiocare.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cheffelo AB (publ) | 1.01bn | 19.47m | 290.31m | 406.00 | 14.91 | 0.6563 | 4.30 | 0.2879 | 1.52 | 1.52 | 78.85 | 34.59 | 1.30 | 43.20 | 81.41 | 2,462,375.00 | 2.51 | -5.33 | 3.08 | -6.69 | 43.33 | 38.75 | 1.93 | -3.95 | 0.8053 | 9.58 | 0.2324 | -- | -7.56 | -5.50 | 112.49 | -- | -8.99 | -- |
| Fodelia Oyj | 574.85m | 14.13m | 471.36m | 133.00 | 33.29 | 2.98 | 12.33 | 0.82 | 0.149 | 0.149 | 6.06 | 1.67 | 1.80 | 6.94 | 10.46 | 368,154.30 | 4.43 | -- | 6.90 | -- | 46.78 | -- | 2.46 | -- | 0.6173 | 3.10 | 0.3416 | -- | 17.64 | -- | 14,705.78 | -- | -- | -- |
| Skane mollan AB | 273.49m | 14.92m | 643.56m | 29.00 | 43.13 | 3.93 | 29.94 | 2.35 | 1.34 | 1.34 | 24.65 | 14.74 | 1.37 | 3.66 | 9.56 | 9,349,414.00 | 7.49 | 10.07 | 8.54 | 11.25 | 16.44 | 20.55 | 5.46 | 7.88 | 3.34 | -- | 0.00 | 78.90 | -0.3041 | 9.23 | -28.81 | 9.31 | 10.03 | 4.94 |
| HKScan Oyj | 13.66bn | -248.89m | 768.82m | 3.62k | -- | 0.3227 | 2.03 | 0.0563 | -0.2176 | -0.2884 | 12.84 | 2.17 | 1.28 | 11.35 | 9.22 | 321,059.90 | -1.71 | -1.29 | -2.37 | -1.95 | 6.77 | 31.45 | -1.34 | -0.8316 | 0.7018 | 0.6705 | 0.5632 | -- | 5.99 | -7.48 | 0.4695 | -- | -- | -- |
| Hofseth Biocare ASA | 218.51m | -106.68m | 869.18m | 62.00 | -- | 20.78 | -- | 3.98 | -0.270 | -0.270 | 0.5531 | 0.1059 | 0.5455 | 1.52 | 15.11 | -- | -26.63 | -30.07 | -56.38 | -46.48 | 30.58 | 20.11 | -48.82 | -99.69 | 0.1924 | -24.68 | 0.7688 | -- | 81.42 | 29.18 | 22.35 | -- | 19.20 | -- |
| Apetit Oyj | 2.06bn | 113.88m | 986.45m | 338.00 | 8.56 | 0.8013 | 5.46 | 0.4788 | 1.55 | 1.55 | 28.56 | 16.60 | 1.41 | 3.74 | 23.56 | 519,230.80 | 7.81 | 1.75 | 9.34 | 2.58 | 30.83 | 19.91 | 5.53 | 1.05 | 1.02 | -- | 0.0726 | 125.68 | -3.41 | -7.55 | 203.13 | -- | 2.28 | 13.40 |
| Midsona AB | 3.83bn | -53.46m | 1.12bn | 765.00 | -- | 0.371 | 10.67 | 0.2925 | -0.3644 | -0.3644 | 26.08 | 20.54 | 0.7983 | 4.40 | 10.36 | 4,958,170.00 | -1.12 | -0.7919 | -1.30 | -0.9301 | 25.76 | 26.25 | -1.40 | -1.05 | 0.9189 | 1.07 | 0.1966 | -- | -2.72 | 5.87 | 89.42 | -- | -13.22 | -- |
| Raisio Oyj | 2.58bn | 204.28m | 3.59bn | 338.00 | 15.59 | 1.14 | 11.08 | 1.39 | 0.1208 | 0.1189 | 1.52 | 1.65 | 0.6695 | 4.13 | 7.33 | 649,408.30 | 5.34 | 5.94 | 5.95 | 6.66 | 27.47 | 27.28 | 7.97 | 8.75 | 3.33 | -- | 0.087 | 117.00 | -0.5888 | -0.7744 | 40.00 | 7.66 | 5.84 | -2.64 |
| Holder | Shares | % Held |
|---|---|---|
| Bonafide Wealth Management AG (Liechtenstein)as of 30 Jun 2023 | 23.55m | 5.96% |
| BlackRock Investment Management (UK) Ltd.as of 29 Feb 2024 | 5.05m | 1.28% |
| Keskin�inen Ty�el�kevakuutusyhti� Varmaas of 31 Dec 2020 | 2.57m | 0.65% |
| DNB Asset Management ASas of 29 Feb 2024 | 2.43m | 0.62% |
| BlackRock Advisors (UK) Ltd.as of 29 Feb 2024 | 1.45m | 0.37% |
| Mediolanum International Funds Ltd.as of 29 Dec 2023 | 236.61k | 0.06% |
| Dimensional Fund Advisors LPas of 29 Feb 2024 | 27.30k | 0.01% |
| SSgA Funds Management, Inc.as of 04 Apr 2024 | 3.91k | 0.00% |
